<?xml version="1.0" encoding="UTF-8"?>
<document id="29517678">
	<sentence id="s1" text="The present study was aimed to investigate the relationship between the expression of collagen type V alpha 2 chain (negative regulation of endodermal cell differentiation) and clinical outcomes of patients with bladder cancer.Chi-square test and log-rank-based survival analysis were performed to assess the correlation of COL5A2 expression with clinical characteristics and survivals of patients with bladder cancer using GSE13507.">
		<entity id="s1.e1" charOffset="117-171"
			type="GO" text="negative regulation of endodermal cell differentiation" ontology_id="GO_1903225"/>
		<entity id="s1.e2" charOffset="220-226"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<pair id="s1.p1" e1="s1.e1"
		    e2="s1.e2" pgr="false"/>
	</sentence>
	<sentence id="s2" text="Gene negative regulation of transcription, DNA-templated enrichment analysis was conducted to study the relevant mechanisms.Bladder cancer patients in negative regulation of endodermal cell differentiation low expression group were associated with better invasiveness (P AAAA .0001), tumor grade (P = .001), T staging (P AAAA .0001), N staging (P = .002), cancer specific survival (P AAAA .0001), overall survival (P AAAA .0001), and a trend of better M staging (P = .053) than those in COL5A2 high expression group.COL5A2 might affect the progression of bladder cancer through AAAAAACoagulation,AAAAAA AAAAAAHypoxia,AAAAAA AAAAAAApical junction,AAAAAA AAAAAAUltraviolet response,AAAAAA AAAAAAEpithelial mesenchymal transition,AAAAAA AAAAAAAngiogenesis,AAAAAA AAAAAApositive regulation of protein phosphorylation (positive regulation of protein phosphorylation proto-oncogene, GTPase) signaling,AAAAAAComplement,AAAAAAIL2-STAT5-signaling,AAAAAA AAAAAAInflammatory response,AAAAAA AAAAAAIL6-JAK-STAT3-signaling,AAAAAA AAAAAAMyogenesis,AAAAAA AAAAAATNF a signaling,AAAAAA AAAAAAApoptosis,AAAAAA and AAAAAAHedgehog-signaling.AAAAA;Our results demonstrated that COL5A2 was correlated with poor clinical outcomes and survivals of patients with bladder cancer, suggesting that it could be regarded as a biomarker of bladder cancer">
		<entity id="s2.e1" charOffset="5-56"
			type="GO" text="negative regulation of transcription, DNA-templated" ontology_id="GO_0045892"/>
		<entity id="s2.e2" charOffset="132-138"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<entity id="s2.e3" charOffset="151-205"
			type="GO" text="negative regulation of endodermal cell differentiation" ontology_id="GO_1903225"/>
		<entity id="s2.e4" charOffset="236-241"
			type="HP" text="tumor" ontology_id="HP_0002664"/>
		<entity id="s2.e5" charOffset="718-764"
			type="GO" text="positive regulation of protein phosphorylation" ontology_id="GO_0001934"/>
		<pair id="s2.p1" e1="s2.e1"
		    e2="s2.e2" pgr="false"/>
		<pair id="s2.p2" e1="s2.e2"
		    e2="s2.e5" pgr="true"/>
		<pair id="s2.p3" e1="s2.e3"
		    e2="s2.e4" pgr="false"/>
		<pair id="s2.p4" e1="s2.e1"
		    e2="s2.e6" pgr="false"/>
		<pair id="s2.p5" e1="s2.e6"
		    e2="s2.e3" pgr="true"/>
	</sentence>
</document>
